Conventional drivers of liking analysis was extended with a time dimension into temporal drivers of liking (TDOL) based on functional data analysis methodology and non-additive models for multiple-attribute time-intensity (MATI) data. The non-additive models, which consider both direct effects and interaction effects of attributes to consumer overall liking, include Choquet integral and fuzzy measure in the multi-criteria decision-making, and linear regression based on variance decomposition. Dynamics of TDOL, i.e., the derivatives of the relative importance functional curves were also explored. Well-established R packages 'fda', 'kappalab' and 'relaimpo' were used in the paper for developing TDOL. Applied use of these methods shows that the relative importance of MATI curves offers insights for understanding the temporal aspects of consumer liking for fruit chews.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025064PMC
http://dx.doi.org/10.3390/foods7060084DOI Listing

Publication Analysis

Top Keywords

drivers liking
12
non-additive models
12
temporal drivers
8
based functional
8
functional data
8
data analysis
8
fruit chews
8
consumer liking
8
liking
5
liking based
4

Similar Publications

Lung cancer is one of the most frequently diagnosed cancers in the US. African-American (AA) men are more likely to develop lung cancer with higher incidence and mortality rates than European-American (EA) men. Herein, we report high-confidence alternative splicing (AS) events from high-throughput, high-depth total RNA sequencing of lung tumors and non-tumor adjacent tissues (NATs) in two independent cohorts of patients with adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC).

View Article and Find Full Text PDF

Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death.

Neurotherapeutics

January 2025

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK; Leibniz-Institut für Polymerforschung Dresden, Max Bergmann Center of Biomaterials Dresden, Hohe Straße 6, D-01069 Dresden, Germany. Electronic address:

Replacing cells lost during the progression of neurodegenerative disorders holds potential as a therapeutic strategy. Unfortunately, the majority of cells die post-transplantation, which creates logistical and biological challenges for cell therapy approaches. The cause of cell death is likely to be multifactorial in nature but has previously been correlated with hypoxia in the graft core.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

RxY, New York, NY, USA.

Background: Disease-modifying therapies (DMTs) such as lecanemab and aducanumab are recommended for the treatment of patients with confirmed Alzheimer's disease (AD) within the mild cognitive impairment (MCI) or mild stages of dementia. Biomarker testing is required to confirm the presence of amyloid beta for prescription of DMTs. Confirmatory diagnosis at the MCI stage is important to take advantage of the narrow treatment window of currently available DMTs.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Aitia, Somerville, MA, USA.

Background: Amyloid, Tau and neurodegeneration (ATN), the hallmark pathologies of Alzheimer's Disease (AD) translating to measurable biomarkers are important for disease modifying therapeutics.

Method: AD Digital-Twins were built using AITIA's patented A.I.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Mailman School of Public Health, Columbia University, New York, NY, USA.

Exposure to environmental chemicals has been associated with Alzheimer's disease (AD); however, most studies have used a targeted approach to study this relationship. While targeted approaches have been critical to understand mechanisms, they do not reflect real world exposures where an individual is exposed to multiple chemicals at the same time. Exposomics provides the opportunity to use an -omics level approach to understand the environmental drivers of disease by measuring the burden of multiple chemicals at the same time.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!